Skip to content
Wednesday, October 28, 2026 · Today’s edition, 6:30 a.m. ETWed, Oct 28 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

Who holds MAZEMaze Therapeutics

5 funds on our shelf carry Maze Therapeutics — heaviest hand: XPH at 1.85% of its book.

FundWeightFund assetsShares held
XPHState Street SPDR S&P Pharmaceuticals ETFINDEX1.85%$487M265,830
IWCiShares Micro-Cap ETFINDEX0.27%$1.3B107,677
IHEiShares U.S. Pharmaceuticals ETFINDEX0.25%$1.6B123,282
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.11%$112M4,256
IBBiShares Biotechnology ETFINDEX0.08%$10.6B263,255

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.